Universe Pharmaceuticals annual depreciation and amortization
2019
2020
2021
2022
2023
2024
2025
Universe Pharmaceuticals Depreciation & Amortization Growth & History (UPC)
Universe Pharmaceuticals's depreciation and amortization was $517.4M for fiscal 2025.
View full Universe Pharmaceuticals company overviewUniverse Pharmaceuticals annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | $517.4M | $31.7M | +6.53% |
| 2024 | 2024-09-30 | $485.7M | $485.2M | +95369.40% |
| 2023 | 2023-09-30 | $508,785 | −$25,164 | −4.71% |
| 2022 | 2022-09-30 | $533,949 | $87,071 | +19.48% |
| 2021 | 2021-09-30 | $446,878 | $36,799 | +8.97% |
| 2020 | 2020-09-30 | $410,079 | −$8,352 | −2.00% |
| 2019 | 2019-09-30 | $418,431 | — | — |
Universe Pharmaceuticals depreciation and amortization trends
Over the last five fiscal years, Universe Pharmaceuticals's depreciation and amortization increased from $410,079 to $517.4M, a change of $517.0M.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Universe Pharmaceuticals source filings ↗